The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations
Open accessAbstract
The first systems for continuous glucose monitoring (CGM) became available over 15 years ago. Many then believed CGM would revolutionize the use of intensive insulin therapy in diabetes; however, progress toward that vision has been gradual. Although increasing, the proportion of individuals using CGM rather than conventional systems for self-monitoring of blood glucose on a daily basis is still low in most parts of the world. Barriers to uptake include cost, measurement reliability (particularly with earlier-generation systems), human factors issues, lack of a standardized format for displaying results, and uncertainty on how best to use CGM data to make therapeutic decisions. This Scientific Statement makes recommendations for systemic improvements in clinical use and regulatory (pre- and postmarketing) handling of CGM devices. The aim is to improve safety and efficacy in order to support the advancement of the technology in achieving its potential to improve quality of life and health outcomes for more people with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In many countries, the benefits and utility of CGM are now recognized by national and international medical organizations for individuals with insulin-requiring diabetes and/or those at risk for hypoglycemia (16-21).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McCambridge, J., Witton, J., & Elbourne, D. R. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.08.015 · Cited by 2,748
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Self-citationBolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
Rodbard, D. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0417 · Cited by 768
Threshold-based insulin-pump interruption for reduction of hypoglycemia
Bergenstal, R. M., Klonoff, D. C., Garg, S. K., Bode, B. W., Meredith, M., Slover, R. H., Ahmann, A. J., Welsh, J. B., Lee, S. W., & Kaufman, F. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303576 · Cited by 652
Self-citationSafety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644
Self-citationHaak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623
International Hypoglycaemia Study Group (2017) · Diabetes Care · doi:10.2337/dc16-2215 · Cited by 608
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Cited by
Sorted by citations
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Self-citationMaiorino, M. I., Signoriello, S., Maio, A., Chiodini, P., Bellastella, G., Scappaticcio, L., Longo, M., Giugliano, D., & Esposito, K. (2020) · Diabetes Care · doi:10.2337/dc19-1459 · Cited by 364
Glycemic variability: adverse clinical outcomes and how to improve it?
Zhou, Z. G., Sun, B., Huang, S., Zhu, C., & Bian, M. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01085-6 · Cited by 273
Review of methods for detecting glycemic disorders
Bergman, M., Abdul‐Ghani, M. A., DeFronzo, R. A., Manco, M., Sesti, G., Fiorentino, T. V., Ceriello, A., Rhee, M. K., Phillips, L. S., Chung, S. T., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108233 · Cited by 210
Didyuk, O., Econom, N., Guardia, A., Livingston, K., & Klueh, U. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819899394 · Cited by 175
Glycemic variability: how to measure and its clinical implication for type 2 diabetes
Umpierrez, G. E., & P. Kovatchev, B. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.09.010 · Cited by 148
Sherr, J. L., Heinemann, L., Fleming, G. A., Bergenstal, R. M., Bruttomesso, D., Hanaire, H., Holl, R. W., Petrie, J. R., Peters, A. L., & Evans, M. (2022) · Diabetes Care · doi:10.2337/dci22-0018 · Cited by 136
Self-citationTime in range: a new parameter to evaluate blood glucose control in patients with diabetes
Gabbay, M. A. L., Rodacki, M., Calliari, L. E., Vianna, A. G. D., Krakauer, M., Pinto, M. S., Reis, J. S., Puñales, M. K., Miranda, L. G., Ramalho, A. C., et al. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00529-z · Cited by 143
Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners
Ajjan, R., Slattery, D., & Wright, E. E. (2019) · Advances in Therapy · doi:10.1007/s12325-019-0870-x · Cited by 133
Ehrhardt, N. M., & Zaghal, E. A. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818790994 · Cited by 111
The application of simple metrics in the assessment of glycaemic variability
Monnier, L., Colette, C., & Owens, D. R. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.02.008 · Cited by 109
Campbell, F., Murphy, N., Stewart, C., Biester, T., & Kordonouri, O. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12735 · Cited by 102
Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes
Lal, R., Ekhlaspour, L., Hood, K. K., & Buckingham, B. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00174 · Cited by 102
Technology in the management of type 2 diabetes: Present status and future prospects
DALY, A. B., & Hovorka, R. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14418 · Cited by 100
Bergenstal, R. M., Mullen, D. M., Strock, E., Johnson, M. L., & Xi, M. X. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108106 · Cited by 87
Self-citationNeed for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics
Beyond A1C Writing Group (2018) · Diabetes Care · doi:10.2337/dci18-0010 · Cited by 88
Ajjan, R. A., Jackson, N., & Thomson, S. A. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827456 · Cited by 79
Glucose variability: a new risk factor for cardiovascular disease
Belli, M., Bellia, A., Sergi, D., Barone, L., Lauro, D., & Barillà, F. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02097-w · Cited by 68
Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach
Adolfsson, P., Parkin, C. G., Thomas, A., & Krinelke, L. (2018) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2018.14.1.24 · Cited by 65
Monnier, L., Wojtusciszyn, A., Molinari, N., Colette, C., Renard, É., & Owens, D. R. (2020) · Diabetes Care · doi:10.2337/dc19-1549 · Cited by 62
Head-to-head comparison of the accuracy of Abbott FreeStyle Libre and Dexcom G5 mobile
Boscari, F., Galasso, S., Acciaroli, G., Facchinetti, A., Marescotti, M. C., Avogaro, A., & Bruttomesso, D. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.01.003 · Cited by 59
Deiss, D., Szadkowska, A., Gordon, D., Mallipedhi, A., Schütz-Fuhrmann, I., Aguilera, E., Ringsell, C., Block, C. E. M. D., & Irace, C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0397 · Cited by 56
Clinical recommendations for the use of the ambulatory glucose profile in diabetes care
Kröger, J., Reichel, A., Siegmund, T., & Ziegler, R. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819883032 · Cited by 51
Hypoglycemia: New Definitions and Regulatory Implications
Ratner, R. E. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0113 · Cited by 52
Zeng, Q., Xu, M., Hu, W., Cao, W., Zhan, Y., Zhang, Y., Wang, Q., & Ma, T. (2023) · Biosensors · doi:10.3390/bios13050537 · Cited by 44
Valente, T., & Arbex, A. K. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200716201550 · Cited by 44
Sandig, D., Grimsmann, J. M., Reinauer, C., Melmer, A., Zimny, S., Müller-Korbsch, M., Forestier, N., Zeyfang, A., Bramlage, P., Danne, T., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0019 · Cited by 43
Self-citationContinuous glucose monitoring devices: A brief presentation (Review)
Mihai, D. A., Ștefan, S., Stegaru, D., Bernea, E. G., Văcăroiu, I. A., Papacocea, T. M., Lupușoru, M. O. D., Nica, A. E., Ştiru, O., Dragoș, D., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.11097 · Cited by 41
Schlüter, S., Freckmann, G., Heinemann, L., Wintergerst, P., & Lange, K. (2020) · Diabetic Medicine · doi:10.1111/dme.14467 · Cited by 42
Self-citationLucidi, P., Porcellati, F., Bolli, G. B., & Fanelli, C. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1065-6 · Cited by 38
Time-in-range as a target in type 2 diabetes: An urgent need
Saboo, B., Kesavadev, J., Shankar, A., Krishna, M. B., Sheth, S., Patel, V., & Krishnan, G. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e05967 · Cited by 38
Kong, S.-Y., & Cho, M.-K. (2024) · Healthcare · doi:10.3390/healthcare12050571 · Cited by 36
Key indices of glycaemic variability for application in diabetes clinical practice
Monnier, L., Bonnet, F., Colette, C., Renard, É., & Owens, D. R. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101488 · Cited by 35
Piona, C. A., Dovč, K., Mutlu, G. Y., Grad, K., Gregorc, P., Battelino, T., & Bratina, N. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12729 · Cited by 35
A novel semiconductor based wireless electrochemical sensing platform for chronic disease management
Mujeeb-U-Rahman, M., Nazari, M. H., & SENCAN, M. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.09.077 · Cited by 33
Kalra, S., Shaikh, S. S., Priya, G., Baruah, M., Verma, A., Das, A. K., Shah, M., Das, S., Khandelwal, D., Sanyal, D., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00973-0 · Cited by 32
Distinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes
Zhu, J., Volkening, L. K., & Laffel, L. M. (2020) · Diabetes Care · doi:10.2337/dc19-0083 · Cited by 30
Paleczek, A., & Rydosz, A. M. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.135550 · Cited by 30
Riddle, M. C., Gerstein, H. C., & Cefalu, W. T. (2017) · Diabetes Care · doi:10.2337/dci17-0049 · Cited by 30
Monnier, L., Colette, C., Schlienger, J.-L., Bauduceau, B., & Owens, D. R. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.01.007 · Cited by 29
Jangam, S. R., Dunn, T. C., Xu, Y., Hayter, G., & Ajjan, R. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000611 · Cited by 29
Psychosocial Aspects of Diabetes Technology Use
Papadakis, J. L., Anderson, L. M., Garza, K. P., Feldman, M. A., Shapiro, J. B., Evans, M. A., Thompson, L. G., & Weissberg-Benchell, J. A. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.004 · Cited by 29
A systematic review on clinical implication of continuous glucose monitoring in diabetes management
Gillani, S. W., Azhar, A., Mohiuddin, G., & Majeed, R. A. (2020) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_7_20 · Cited by 29
Personalized nutrition for people with diabetes and at risk of diabetes has begun
Chen, R. E., & Chen, G. (2022) · Journal of Future Foods · doi:10.1016/j.jfutfo.2022.06.001 · Cited by 29
Marks, B. E., Wolfsdorf, J. I., Waldman, G., Stafford, D. E. J., & Garvey, K. C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0331 · Cited by 29
Review of the veteran affairs diabetes trial: Lessons learned
Tran, K., & Reaven, P. D. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09558-5 · Cited by 27
Time-in-range and frequency of continuous glucose monitoring: Recommendations for South Asia
Kesavadev, J., Misra, A., Saboo, B., Agarwal, S., Sosale, A., Joshi, S., Hussain, A., Somasundaram, N. P., Basit, A., Choudhary, P., et al. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102345 · Cited by 24
Mario, C. D., Genovese, S., Lanza, G. A., Mannucci, E., Marenzi, G., Sciatti, E., Pitocco, D., the Expert Panel Group, Avogaro, A., Bertuzzi, F., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01598-2 · Cited by 24
Romero‐Castillo, R., Pabón‐Carrasco, M., Picón, N. J., & Ponce‐Blandón, J. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192316364 · Cited by 24
Ghosh, M., & Bora, V. R. (2025) · Discover Medicine · doi:10.1007/s44337-025-00273-1 · Cited by 25
Semenova, D., Silina, Y. E., Koch, M., Micheli, L., Zubov, A., & Gernaey, K. V. (2019) · The Analyst · doi:10.1039/c8an02261e · Cited by 23
Ridder, F. D., den Brinker, M., & Block, C. E. M. D. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819865399 · Cited by 22
Alawadi, F., Alsaeed, M., Bachet, F., Bashier, A. M., Abdulla, K., Abuelkheir, S., Rashid, F., Hussain, A. A. B., Abdelgadir, E., Alsayyah, F., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108466 · Cited by 22
Taylor, P. J., Thompson, C. H., Luscombe‐Marsh, N. D., Wycherley, T. P., Wittert, G., Brinkworth, G. D., & Zajac, I. T. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107814 · Cited by 21
Jin, D., Xu, Z., Zhao, H., Deng, S., Qu, Z., Dou, R., & Liu, W. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.111367 · Cited by 21
Time in Range as a Research Outcome Measure
Timmons, J. G., Boyle, J. G., & Petrie, J. R. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0097 · Cited by 20
Self-citationMannan, A., Akter, F., Chy, N. U. H. A., Alam, N., Rana, M. M., Chowdhury, N. A., & Hasan, M. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267713 · Cited by 20
Bergenstal, R. M. (2023) · Diabetes Spectrum · doi:10.2337/dsi23-0005 · Cited by 19
Self-citationEvolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment
Wright, E. E., & Subramanian, S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0191 · Cited by 19
Homer, A. R., Taylor, F., Dempsey, P. C., Wheeler, M. J., Sethi, P., Grace, M. S., GREEN, D. J., Cohen, N. D., Larsen, R. N., Kingwell, B. A., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.07.001 · Cited by 22
Diabetes Care Editors’ Expert Forum 2018: Managing Big Data for Diabetes Research and Care
Riddle, M. C., Blonde, L., Gerstein, H. C., Gregg, E. W., Holman, R. R., Lachin, J. M., Nichols, G. A., Turchin, A., & Cefalu, W. T. (2019) · Diabetes Care · doi:10.2337/dci19-0020 · Cited by 21
Forecasting glucose values for patients with type 1 diabetes using heart rate data
Giancotti, R., Bosoni, P., Vizza, P., Tradigo, G., Gnasso, A., Guzzi, P. H., Bellazzi, R., Irace, C., & Veltri, P. (2024) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2024.108438 · Cited by 18
Ritholz, M. D., Henn, O., Atakov-Castillo, A., Wolpert, H. A., Edwards, S., Fisher, L., & Toschi, E. (2019) · JMIR Diabetes · doi:10.2196/14032 · Cited by 17
Préau, Y., Armand, M., Galie, S., Schaepelynck, P., & Raccah, D. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0515 · Cited by 16
Using Flash Continuous Glucose Monitoring in Primary Practice
Hirsch, I. B., & Wright, E. E. (2018) · Clinical Diabetes · doi:10.2337/cd18-0054 · Cited by 15
Cuesta–Frau, D., Novák, D., Burda, V., Molina, Á., Vargas, B., Mráz, M., Kaválková, P., Beneš, M., & Haluzı́k, M. (2018) · Entropy · doi:10.3390/e20110871 · Cited by 14
Standardized Hybrid Closed-Loop System Reporting
Shah, V. N., & Garg, S. K. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0622 · Cited by 14
Hirsch, I. B., Nardacci, E., & Verderese, C. A. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0059 · Cited by 12
Blevins, T., Lane, W. S., Rodbard, D., Sindelar, D. K., Fan, L., Ellinor, K., Ilag, L. L., Ly, T. T., & Johnson, J. L. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0030 · Cited by 12
Savoy, A., Holden, R. J., de Groot, M., Clark, D. O., Sachs, G. A., Klonoff, D. C., & Weiner, M. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221137907 · Cited by 11
Carlson, A. L., Mullen, D. M., Mazze, R. S., Strock, E. S., Richter, S. A., & Bergenstal, R. M. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0177 · Cited by 10
Self-citationMonnier, L., Colette, C., & Owens, D. R. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.101118 · Cited by 11
de Valk, H. W., Lablanche, S., Bosi, E., Choudhary, P., Silva, J. D., Castañeda, J., Vorrink, L., de Portu, S., & Cohen, O. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0222 · Cited by 9
Block, C. E. M. D., CHENG, A. Y. Y., Christensen, T. B., Patted, U. R. H., & Ginovker, A. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01429-x · Cited by 8
Sperling, M. A., Wolfsdorf, J. I., Menon, R. K., Tamborlane, W. V., Maahs, D. M., Battelino, T., & Phillip, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00021-x · Cited by 11
Continuous Glucose Monitors as Wearable Lifestyle Behavior Change Tools in Obesity and Diabetes
Schembre, S. M., Liao, Y., & Jospe, M. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_43 · Cited by 9
Simulation Platform Development for Diabetes and Technology Self-Management
Faulds, E. R., Rayo, M. F., Lewis, C. J., Noble, C. W., Gifford, R. C., Happ, M. B., Joyce, L., & Dungan, K. M. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211029303 · Cited by 7
Gjorup, A. L. T., Snoek, F. J., & van Duinkerken, E. (2021) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2021.727029 · Cited by 9
Yoon, M. K., Kang, J. G., Lee, S. J., Ihm, S., Huh, K. B., & Kim, C. S. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.2.319 · Cited by 7
Deeb, A., Muammar, T., Alsaffar, H., Sedaghat, S., Hassani, N. A., Odeh, R., Alkhayyat, H., Sinani, A. A., Attia, N. A., Adhami, S., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108671 · Cited by 7
Automated Insulin Delivery Systems: Today, Tomorrow and User Requirements
Giménez, M., Conget, I., & Oliver, N. S. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211029937 · Cited by 7
Hobbs, A., Thus, M., Couper, J., Tham, E., & Fairchild, J. M. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13293 · Cited by 7
Gibb, F. W., Jennings, P. L., Leelarathna, L., & Wilmot, E. G. (2020) · British Journal of Diabetes · doi:10.15277/bjd.2020.240 · Cited by 6
Self-Monitoring of Blood Glucose in Patients with Insulin-Treated Type 2 Diabetes Mellitus
Kim, K. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.26 · Cited by 6
Riddle, M. C., Bakris, G. L., Boulton, A. J. M., Blonde, L., D’Alessio, D. A., Greene, E. L., de Groot, M., Hood, K. K., Hu, F. B., Kahn, S. E., et al. (2018) · Diabetes Care · doi:10.2337/dci18-0035 · Cited by 6
Historical aspects of diagnosis and control of diabetes mellitus
Кузина, И. А., Валерьевна, Г. Е., Martirosian, N. S., Эдуардовна, Т. М., Недосугова, Л. В., Алексеевич, Т. А., & Petunina, N. A. (2022) · Terapevticheskii arkhiv · doi:10.26442/00403660.2022.10.201890 · Cited by 5
Thomas, A., Haak, T., Tombek, A., Kulzer, B., Ehrmann, D., Kordonouri, O., Kröger, J., Schubert-Olesen, O., Kolassa, R., Siegmund, T., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241267768 · Cited by 5
Self-citationJensen, M. H., Dethlefsen, C., Hejlesen, O. K., & Vestergaard, P. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819848721 · Cited by 5
Karlsson, T., Augustin, H., Lindqvist, M., Otten, J., Petersson, K., Lindholm, E., Mogren, I., & Winkvist, A. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106706 · Cited by 5
Monnier, L., Colette, C., & Owens, D. R. (2018) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30058-0 · Cited by 5
Yoshino, S., Yamada, E., Okada, S., Nakajima, Y., Shibusawa, R., Uehara, R., Matsumoto, S., Horiguchi, K., Ishida, E., Saito, T., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej19-0488 · Cited by 5
Liu, Y., Yuan, J., Zhang, Y., Ma, T., Ji, Q., Tian, S. L., & Liu, C. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111632 · Cited by 4
Glucose Lowering Strategies for Cardiac Benefits: Pathophysiological Mechanisms
BAJAJ, H. S., & Zinman, B. (2018) · Physiology · doi:10.1152/physiol.00004.2018 · Cited by 4
Ortiz‐Rubio, P., Oladunjoye, A. O., Agus, M. S. D., & Steil, G. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12752 · Cited by 4
Rodríguez‐Gutiérrez, R., Salcido‐Montenegro, A., González‐González, J. G., & McCoy, R. G. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001906 · Cited by 5
Tyagi, S., Sng, K., Ng, D. W. L., Teo, V., Thio, S. M., He, J. C. E., Beh, C. Y., Cheah, M. H., Toh, N., Chen, J., et al. (2025) · BMC Primary Care · doi:10.1186/s12875-025-03001-x · Cited by 3
Monnier, L., Halimi, S., & Colette, C. (2018) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30007-5 · Cited by 3
Vallarino, C. R., Wong-Jacobson, S., Benneyworth, B. D., & Meadows, E. S. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211052081 · Cited by 4
Surgical options for glycaemic control in Type 1 diabetes
Yeung, K., Reddy, M., & Purkayastha, S. (2019) · Diabetic Medicine · doi:10.1111/dme.13885 · Cited by 2
Advancing Diabetes Quality Measurement in the Era of Continuous Glucose Monitoring
Khan, M., Wahid, N., Musser, T., Bergenstal, R. M., Ebekozien, O. A., Snow, K. J., Thomas, K., & Aprigliano, C. M. (2023) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106231163518 · Cited by 3
Self-citation
Metadata
- Authors
- Petrie, J. R., Peters, A. L., Bergenstal, R. M., Holl, R. W., Fleming, G. A., & Heinemann, L.
- Affiliations
- University of Glasgow (GB)
- University of Southern California (US)
- Park Nicollet Health Services (US)
- Universität Ulm (DE)
- Kinexum, Harpers Ferry, WV
- Science & Co, Dusseldorf, Germany
- Corresponding author
- Petrie, John R.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-10-25
- Volume
- 40
- Issue
- 12
- Pages
- 1614-1621
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2766548367
- Cited by
- 135
- References
- 53
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 12 · 2021: 18 · 2020: 21 · 2019: 25 · 2018: 28 · 2017: 1
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, diabetes management, intensive insulin therapy, measurement reliability, human factors, regulatory oversight, self-monitoring of blood glucose
- MeSH terms
- Blood Glucose, Cost-Benefit Analysis, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Europe, Humans, Insulin, Insulin Infusion Systems, Quality of Life, Societies, Medical, United States, Blood Glucose Self-Monitoring, Meta-Analysis as Topic, Reproducibility of Results, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
